Literature DB >> 9516228

Progress and problems in the fight against AIDS.

B Hirschel, P Francioli.   

Abstract

Entities:  

Keywords:  Acquired Immunodeficiency Syndrome; Demographic Factors; Developed Countries; Developing Countries; Diseases; Drugs--therapeutic use; Economic Factors; Hiv Infections; Inequalities; Measurement; Morbidity; Mortality; Mortality Decline; Obstacles; Organization And Administration; Population; Population Dynamics; Prevalence--changes; Progress Report; Research Methodology; Socioeconomic Factors; Treatment; Viral Diseases

Mesh：

Substances：

Year:  1998        PMID： 9516228     DOI： 10.1056/NEJM199803263381310

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  9 in total

1.  The concurrent validity and responsiveness of the health utilities index (HUI 3) among patients with advanced HIV/AIDS.

Authors:  Bohdan Nosyk; Huiying Sun; Nick Bansback; Daphne P Guh; Xin Li; Paul Barnett; Ahmed Bayoumi; Susan Griffin; Vilija Joyce; Mark Holodniy; Doug K Owens; Aslam H Anis
Journal:  Qual Life Res       Date:  2009-06-27       Impact factor: 4.147

2.  Human immunodeficiency virus mutation and changes in CD4 T-cell levels during antiretroviral therapy.

Authors:  M Battegay
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

Review 3.  A comparative review of health-related quality-of-life measures for use in HIV/AIDS clinical trials.

Authors:  Darren J Clayson; Diane J Wild; Paul Quarterman; Isabelle Duprat-Lomon; Maria Kubin; Stephen Joel Coons
Journal:  Pharmacoeconomics       Date:  2006       Impact factor: 4.981

4.  High-level resistance to 3'-azido-3'-deoxythimidine due to a deletion in the reverse transcriptase gene of human immunodeficiency virus type 1.

Authors:  T Imamichi; T Sinha; H Imamichi; Y M Zhang; J A Metcalf; J Falloon; H C Lane
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

5.  The M230L nonnucleoside reverse transcriptase inhibitor resistance mutation in HIV-1 reverse transcriptase impairs enzymatic function and viral replicative capacity.

Authors:  Hong-Tao Xu; Yudong Quan; Susan M Schader; Maureen Oliveira; Tamara Bar-Magen; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2010-03-22       Impact factor: 5.191

6.  Discordant outcomes following failure of antiretroviral therapy are associated with substantial differences in human immunodeficiency virus-specific cellular immunity.

Authors:  David A Price; George Scullard; Annette Oxenius; Ruth Braganza; Simon A Beddows; Shamim Kazmi; John R Clarke; Gabriele E Johnson; Jonathan N Weber; Rodney E Phillips
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

7.  State Implementation of the AIDS Drug Assistance Programs.

Authors:  Robert J Buchanan; Scott R Smith
Journal:  Health Care Financ Rev       Date:  1998

8.  Profile of Medicare Beneficiaries With AIDS: Application of an AIDS Casefinding Algorithm.

Authors:  Nancy J Fasciano; Ann L Cherlow; Barbara J Turner; Craig V Thornton
Journal:  Health Care Financ Rev       Date:  1998

9.  Commentary on using the SF-36 or MOS-HIV in studies of persons with HIV disease.

Authors:  Jim Shahriar; Thomas Delate; Ron D Hays; Stephen Joel Coons
Journal:  Health Qual Life Outcomes       Date:  2003-07-09       Impact factor: 3.186
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.